Cargando…
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
A number of cell surface molecules with specificity to tumour cells have been identified and monoclonal antibodies (mAb) to some of these antigens have been used for targeting tumour cells in vivo. We have sought to link the powerful effector mechanisms of cytotoxic T-cells with the specificity of m...
Autores principales: | Ogg, G S, Dunbar, P R, Cerundolo, V, McMichael, A J, Lemoine, N R, Savage, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374430/ https://www.ncbi.nlm.nih.gov/pubmed/10737389 http://dx.doi.org/10.1054/bjoc.1999.1042 |
Ejemplares similares
-
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes
por: Savage, P, et al.
Publicado: (2002) -
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region
por: Wooldridge, Linda, et al.
Publicado: (2007) -
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000) -
FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils
por: Ottonello, L, et al.
Publicado: (1999) -
Susceptibility of HBZ and Tax expressing primary HTLV-1+ T cell clones to CTL lysis
por: Rowan, Aileen G, et al.
Publicado: (2011)